New Non-Toxic Drug for AIDS
American Society for Microbiology (ASM)A trial of this new treatment for HIV/AIDS suggests that it can stimulate the immune system to produce increased CD4 cells without an accompanying rise in HIV viral load. Patients who received Reticulose also gained weight and their clinical condition improved compared to controls.